Diginex’s Twin Deadlines: A $1.5 Billion All-Stock Deal and a Nasdaq Survival Clock

Diginex shares trade at $1.82 vs. $10.56 valuation for Resulticks deal; reverse stock split buys time until Sept 2026 to avoid Nasdaq expulsion.

The numbers tell a stark story. Diginex has valued its own shares at $10.56 apiece for a blockbuster acquisition, yet the market prices them at just $1.82. That gap is the central tension in a high-stakes gambit that could either transform the ESG specialist into a marketing technology powerhouse or see it booted from the Nasdaq.

A Share Consolidation Buys Time

To stave off delisting, Diginex enacted an 8-for-1 reverse stock split at the end of April, slashing its outstanding shares to roughly 29 million. The move came after the company received a warning from the Nasdaq — its stock had languished below the $1 threshold for weeks. Now, the RegTech firm has until September 21, 2026, to demonstrate a sustained recovery above that level. Failure could mean expulsion from the exchange, though a deadline extension remains theoretically possible.

Shareholders had already paved the way for this restructuring. At an extraordinary general meeting on April 13, 99.7% of votes cast — representing about 44% of eligible shares — approved the consolidation and a broader capital reorganization. The company now has authorized capital of 495 million common shares and 5 million preferred shares. Existing special rights, including those held by investment vehicle Rhino Ventures, remain untouched.

The $1.5 Billion Bet on Resulticks

While fighting for its Nasdaq listing, Diginex is simultaneously pursuing a transformative acquisition. The company plans to buy Resulticks, a marketing technology provider, in an all-stock deal valued at roughly $1.5 billion.

The original reference price was set at $1.32 per share before the reverse split. Post-consolidation, that figure adjusted to $10.56 — a level the stock has not come close to touching. At the last close, shares traded at $1.82, underscoring deep investor skepticism.

The math is telling. Instead of issuing over 1.1 billion shares for the deal, Diginex will now issue roughly 141.7 million. But even that reduced number values the company internally at a premium the market refuses to acknowledge.

Resulticks itself brings compelling financials. The target generated around $150 million in revenue in 2025 with a 32% EBITDA margin, and has averaged roughly 70% annual growth over the past five years. Management projects 2026 revenue of $190 million to $210 million, climbing to $250 million to $280 million by 2027.

Unmet Conditions and a Tight Window

The deal’s closing is far from guaranteed. Several conditions must be satisfied first: shareholder approval for the share issuance, Nasdaq clearance for the new stock, multiple regulatory green lights, and the cancellation of nearly all founder warrants.

Diginex is targeting a closing within 30 to 45 days of signing — meaning by the end of May at the latest. None of the conditions are considered certain.

A Business Model in Flux

The Resulticks acquisition would dramatically expand Diginex’s scope. The company has historically focused on ESG data collection and compliance. Adding Resulticks would bring real-time decision-making tools and customer engagement capabilities.

In parallel, Diginex is merging its four existing operating units — including Plan A.Earth and The Remedy Project — into a single integrated technology platform. The company appointed a Chief Operating Officer and a Chief Administrative Officer in early April to oversee the integration. The transformation shifts Diginex from a sustainability and compliance platform toward a broader enterprise intelligence and loyalty platform.

Two Clocks, Little Margin for Error

Diginex faces twin deadlines with little room to maneuver. The Resulticks deal must close by late May. Separately, the Nasdaq compliance clock runs until September 21, 2026.

The company’s current liquidity ratio stands at 3.56, providing some buffer. But with negative earnings and a stock price trading at a fraction of the internal deal valuation, the margin for error is thin. If the acquisition stalls or the reverse split fails to stabilize the share price, the September deadline will loom large.